Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study).

Yujiro NishizawaNaotsugu HaraguchiHirotoshi KimYoshihito IdeKen NakataShu OkamuraToshihiro KudoTaroh SatohMamoru UemuraChu MatsudaTsunekazu MizushimaKohei MurataYuichiro DokiHidetoshi Eguchi

Published in: BMC cancer (2021)

UMIN Clinical Trials Registry ( UMIN000006706 ). Date of registration: NOV/11/2011. URL of trial registry record: https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007920.

Keyphrases

wild type
phase ii study
open label
clinical trial
phase iii
phase ii
placebo controlled
double blind
stem cells
transcription factor
study protocol
locally advanced
monoclonal antibody
minimally invasive
randomized controlled trial
squamous cell carcinoma
radiation therapy
rectal cancer